- Generic name
- Ticagrelor
- Strength
- 60 mg
- Dosage form
- Tablet
- Manufactured by
- Opsonin Pharma Limited
Brirel 60 Tablet
About Brirel 60 Tablet
Made by Opsonin Pharma Limited, Brirel 60 is a tablet whose active ingredient is Ticagrelor. This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction.
There are 13 brands of Ticagrelor listed in Bangladesh. The lowest listed price is Belinta 60 mg Tablet at ৳ 35.00 per unit.
What is Brirel 60 Tablet?
Brirel 60 60 mg tablet is a medicine made by Opsonin Pharma Limited. It is prescribed for adults who have had an acute coronary syndrome, such as unstable angina or a heart attack, including those treated with medicines alone or with procedures like angioplasty or bypass surgery. Its active ingredient is Ticagrelor, which belongs to a group of medicines called anti-platelet drugs. The doctor decides the dose, the course and how long treatment continues.
Uses of Brirel 60
This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction. It is prescribed whether the patient is managed with medicines alone or with procedures such as percutaneous coronary intervention or coronary artery bypass grafting. Brirel 60 is used in adults to help prevent atherothrombotic events after an acute coronary syndrome. Your doctor will decide if it is suitable for you.
How to use Brirel 60
It is usually taken together with aspirin, and the doctor decides the aspirin strength that suits you. Swallow the tablet with water. Brirel 60 is taken by mouth. Shake the bottle well before each use. If you miss a dose, ask the doctor or pharmacist what to do; the product information advises taking only the next scheduled tablet and not doubling up. Do not stop or change the medicine on your own, because stopping can raise the risk of heart attack, stent thrombosis and death.
Side effects of Brirel 60
The doctor can advise whether you need review or a change in treatment. Call the doctor promptly if you notice unusual or prolonged bleeding, breathing difficulty, or any side effect that worries you or does not settle. Because it affects platelets, bleeding is a particular concern. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Always tell the doctor and pharmacist about all medicines you take, and ask them first before starting or stopping anything. It is not for people with moderate to severe liver problems or with allergies to the ingredients. Brirel 60 increases the risk of bleeding, so tell the doctor about any bleeding problem, peptic ulcer or past bleeding in the brain.
Frequently asked questions
What is Brirel 60 used for?
This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction. It is prescribed whether the patient is managed with medicines alone or with procedures such as percutaneous coronary intervention or coronary artery bypass grafting.
How should I take Brirel 60?
It is usually taken together with aspirin, and the doctor decides the aspirin strength that suits you. Swallow the tablet with water.
What should I watch for while using Brirel 60?
The doctor can advise whether you need review or a change in treatment. Call the doctor promptly if you notice unusual or prolonged bleeding, breathing difficulty, or any side effect that worries you or does not settle.
Is Brirel 60 safe for everyone?
Always tell the doctor and pharmacist about all medicines you take, and ask them first before starting or stopping anything. It is not for people with moderate to severe liver problems or with allergies to the ingredients.
Indications
Pharmacology
Dosage & Administration
A patient who misses a dose of Ticagrelor should take only one 90 mg tablet (the next dose) at its scheduled time. Patients treated with Clopidogrel can be directly switched to Ticagrelor if needed. Switching from prasugrel to ticagrelor has not been investigated.
Treatment is recommended for up to 12 months unless discontinuation of Ticagrelor is clinically indicated. Ticagrelor can be administered with or without food.
Interaction
CYP3A inducers: Avoid use with potent inducers of CYP3A (e.g., rifampin, dexamethasone, phenytoin,carbamazepine and phenobarbital).
Aspirin: Use of Ticagrelor with aspirin maintenance doses above 100 mg reduced the effectiveness ofTicagrelor.
Simvastatin, Lovastatin: Ticagrelor will result in higher serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4. Avoid simvastatin and lovastatin doses greater than 40 mg.
Digoxin: Because of inhibition of the P-glycoprotein transporter, monitor digoxin levels with initiation of or any change in ticagrelor therapy.
Other Concomitant Therapy: Ticagrelor can be administered with unfractionated or low-molecular-weight heparin, GPIIb/llla inhibitors, proton pump inhibitors, beta-blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers.
Contraindications
- Hypersensitivity to Ticagrelor or to any of the excipients
- Active pathological bleeding (peptic ulcer)
- History of intracranial haemorrhage
- Moderate to severe hepatic impairment
- Co-administration of Ticagrelor with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, nefazodone, ritonavir, and atazanavir)
Side Effects
Pregnancy & Lactation
Nursing mothers: Available pharmacodynamic/toxicological data in animals have shown excretion of Ticagrelor and its active metabolites in milk. A risk to newborns/infants cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from ticagrelor therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the women.
Precautions & Warnings
Concomitant Aspirin Maintenance Dose: Use of Ticagrelor with maintenance doses of aspirin above 100 mg decreased the effectiveness of Ticagrelor. Therefore, after the initial loading dose of aspirin (usually 325 mg), use Ticagrelor with a maintenance dose of aspirin of 75-100 mg.
Moderate Hepatic Impairment: Ticagrelor has not been studied in patients with moderate hepatic impairment.
Discontinuation of Ticagrelor: Discontinuation of Ticagrelor will increase the risk of myocardial infarction, stent thrombosis, and death.
Overdose Effects
Storage Conditions
Alternative brands of Ticagrelor
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.